14 results match your criteria: "Irvine Clinical Research[Affiliation]"
Neurology
November 2024
From the Seattle University (M.-K.S.), Washington; George Washington University (Y.C., A.A., N.M.D., E.Z.), Washington, DC; DC VA Medical Center (A.A.), Washington, DC; University of Alabama at Birmingham (J.M.R.); Irvine Clinical Research (E.Z.), California.
Background And Objectives: Cerebral amyloid angiopathy (CAA) is common in older adults and is associated with dementia. Less is known whether this association is mediated by Alzheimer disease (AD) neuropathologic changes, the examination of which was the objective of this study.
Methods: This was a retrospective cross-sectional examination of the Kaiser Permanente Washington database of the Adult Changes in Thought (ACT) autopsy cohort with information on CAA, dementia, the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) (amyloid neuritic plaques), and Braak (tau neurofibrillary tangles).
Background: Hypertension and physical inactivity are risk factors for stroke. The effect of cardiorespiratory fitness (CRF) on stroke risk in patients with hypertension has not been assessed. We evaluated stroke incidence in patients with hypertension according to CRF and changes in CRF.
View Article and Find Full Text PDFWe present a novel explainable artificial intelligence (XAI) method to assess the associations between the temporal patterns in the patient trajectories recorded in longitudinal clinical data and the adverse outcome risks, through explanations for a type of deep neural network model called Hybrid Value-Aware Transformer (HVAT) model. The HVAT models can learn jointly from longitudinal and non-longitudinal clinical data, and in particular can leverage the time-varying numerical values associated with the clinical codes or concepts within the longitudinal data for outcome prediction. The key component of the XAI method is the definitions of two derived variables, the temporal mean and the temporal slope, which are defined for the clinical concepts with associated time-varying numerical values.
View Article and Find Full Text PDFInt J Cerebrovasc Dis Stroke
January 2024
Veterans Affairs Medical Center, George Washington University, and School of Medicine, Georgetown University, Washington, DC, USA.
Cerebral microinfarcts are common in older adults and are associated with cognitive impairment. Less is known about sex-related variation in the relationship between cerebral microinfarcts and dementia in older adults, the examination of which was the objective of this study. This case-control study was based on the 727 participants (419 women) in the Adult Changes in Thought (ACT) autopsy data.
View Article and Find Full Text PDFJ Clin Med
October 2023
School of Medicine, University of Texas Southwestern, Dallas, TX 75390, USA.
Anti-amyloid therapies (AATs), such as anti-amyloid monoclonal antibodies, are emerging treatments for people with early Alzheimer's disease (AD). AATs target amyloid β plaques in the brain. Amyloid-related imaging abnormalities (ARIA), abnormal signals seen on magnetic resonance imaging (MRI) of the brain in patients with AD, may occur spontaneously but occur more frequently as side effects of AATs.
View Article and Find Full Text PDFJ Clin Med
September 2023
Biomedical Informatics Center and School of Medicine & Health Sciences, George Washington University, Washington, DC 20052, USA.
Mid-life high blood pressure (BP) is a risk factor for cerebral microinfarcts. Less is known about the relationship between late-life BP and cerebral microinfarcts, the examination of which is the objective of the current study. This case-control study analyzed data from 551 participants (94.
View Article and Find Full Text PDFJ Pers Med
June 2023
Department of Clinical Research and Leadership, School of Medicine and Health Sciences, George Washington University, Washington, DC 20037, USA.
Transformer is the latest deep neural network (DNN) architecture for sequence data learning, which has revolutionized the field of natural language processing. This success has motivated researchers to explore its application in the healthcare domain. Despite the similarities between longitudinal clinical data and natural language data, clinical data presents unique complexities that make adapting Transformer to this domain challenging.
View Article and Find Full Text PDFJ Clin Med
June 2023
Biomedical Informatics Center, School of Medicine & Health Sciences, George Washington University, Washington, DC 20052, USA.
Cerebral microinfarcts are associated with cognitive impairment and dementia. Small vessel diseases such as cerebral arteriolosclerosis and cerebral amyloid angiography (CAA) have been found to be associated with microinfarcts. Less is known about the associations of these vasculopathies with the presence, numbers, and location of microinfarcts.
View Article and Find Full Text PDFJ Clin Med
March 2023
The School of Medicine & Health Sciences, George Washington University, Washington, DC 20037, USA.
Alzheimer's disease (AD) is characterized by cognitive impairment in the presence of cerebral amyloid plaques and neurofibrillary tangles. Less is known about the characteristics and predictors of resilience to cognitive impairment in the presence of neuropathological evidence of AD, the focus of this study. Of 3170 adults age ≥65 years in the National Alzheimer's Coordinating Center (NACC) brain autopsy cohort, 1373 had evidence of CERAD level moderate to frequent neuritic plaque density and Braak stage V-VI neurofibrillary tangles.
View Article and Find Full Text PDFTransformer is the latest deep neural network (DNN) architecture for sequence data learning that has revolutionized the field of natural language processing. This success has motivated researchers to explore its application in the healthcare domain. Despite the similarities between longitudinal clinical data and natural language data, clinical data presents unique complexities that make adapting Transformer to this domain challenging.
View Article and Find Full Text PDFAlzheimers Dement
October 2023
Washington DC VA Medical Center, Washington, DC, USA.
J Pers Med
January 2023
Department of Clinical Research and Leadership, School of Medicine and Health Sciences, George Washington University, Washington, DC 20037, USA.
Deep neural network (DNN) is a powerful technology that is being utilized by a growing number and range of research projects, including disease risk prediction models. One of the key strengths of DNN is its ability to model non-linear relationships, which include covariate interactions. We developed a novel method called interaction scores for measuring the covariate interactions captured by DNN models.
View Article and Find Full Text PDFMed Sci (Basel)
August 2022
Department of Clinical Research and Leadership, George Washington University, Washington, DC 20037, USA.
The high cost and time for developing a new drug or repositioning a partially-developed drug has fueled interest in "repurposing" drugs. Drug repurposing is particularly of interest for Alzheimer's disease (AD) or AD-related dementias (ADRD) because there are no unrestricted disease-modifying treatments for ADRD. We have designed and pilot tested a 3-Step Medication-Wide Association Study Plus (MWAS+) approach to rigorously accelerate the identification of drugs with a high potential to be repurposed for delaying and preventing AD/ADRD: Step 1 is a hypothesis-free exploration; Step 2 is mechanistic filtering; And Step 3 is hypothesis testing using observational data and prospective cohort design.
View Article and Find Full Text PDFCoron Artery Dis
August 2001
Irvine Clinical Research Center, California, USA.
Background: To evaluate the glycemic control, lipid effects, and safety of pioglitazone in patients with type 2 diabetes mellitus.
Design And Methods: Patients (n = 197) with type 2 diabetes mellitus, a hemoglobin A1c (HbA1c) > or = 8.0%, fasting plasma glucose (FPG) > 7.